Skip to main content
Clinical Trials/NCT02242526
NCT02242526
Unknown
Phase 4

Biologic Versus Synthetic Mesh for Treatment of Paraesophageal Hernia

Stony Brook University1 site in 1 country312 target enrollmentSeptember 2014
ConditionsHiatal Hernia

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Hiatal Hernia
Sponsor
Stony Brook University
Enrollment
312
Locations
1
Primary Endpoint
Assess for reappearance of hiatal hernia and reflux
Last Updated
7 years ago

Overview

Brief Summary

The investigators propose a randomized, single blinded controlled trial to compare the use of synthetic versus biologic mesh in hiatal hernia repair, two currently accepted standard of care surgical modalities. The investigators hypothesize that use of synthetic mesh will have lower recurrence at these time points compared to use of biologic mesh.

Detailed Description

Patients will be randomized to either a synthetic (light weight synthetic or biologic (small intestinal submucosa ) mesh group. Endpoints will be measured up to 5 years for the study as a whole, at 6 months and at 60 months. Prior to and following laparoscopic paraesophageal hernia repair, patients will be followed with both subjective and objective measures. Subjective evaluation will include symptomatic/quality of life assessment at 1-, 6-, 24-, and 60- month periods; objective evaluation will include Upper GI study /pH probe study for symptomatic patients and for all patients at 6 and 60 months. The investigators hypothesize that use of synthetic mesh will have lower recurrence at these time points compared to use of biologic mesh.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
August 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female gender
  • Age\>18 years
  • Absence of chronic medical conditions that will affect the quality of life survey, such as fibromyalgia, SLE, Crohn's disease, etc.
  • Able to give informed consent
  • Able and willing to participate in follow-up evaluations
  • Upper GI with a documented hiatal hernia greater than 5cm
  • Paraesophageal hernia with clinically relevant symptoms such as heartburn, chest pain, regurgitation, dysphagia, postprandial abdominal pain, shortness of breath, or early satiety.

Exclusion Criteria

  • Previous surgery of the esophagus and/or the stomach
  • Emergent operation for acute gastric volvulus or strangulation
  • Biopsy consistent with malignancy
  • Body Mass Index (BMI) over 35kg/m2
  • Inability to perform primary closure of crura
  • Active smoking

Outcomes

Primary Outcomes

Assess for reappearance of hiatal hernia and reflux

Time Frame: 6 months, 60 months

Change at 6 and 60 months will be assessed by pH and Upper GI (endoscopy) studies to assess for reappearance of hiatal hernia and reflux.

Secondary Outcomes

  • Quality of Life questionnaire(Quality of Life will be assessed at these time periods after the hernia repair 1, 6, 24, and 60 months)

Study Sites (1)

Loading locations...

Similar Trials